Redmile Group, LLC

Holdings History for FATE THERAPEUTICS INC - Common Stock, $0.001 par value per share (FATE)

Symbol: FATE on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock, $0.001 par value per share
Latest Disclosed Ownership: 17.8M shares
Security Ownership: 14.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Redmile Group, LLC ownership in FATE THERAPEUTICS INC Common Stock, $0.001 par value per share (FATE)

2024-12-26 - Redmile Group, LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 17.8M shares of FATE THERAPEUTICS INC Common Stock, $0.001 par value per share (FATE). This represents 14.9% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Redmile Group, LLC	14.9%		$14.1M	17.8M			$0.79	13D/A	12/20/2024	26 Dec 2024 21:00:09

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	1.48%	-0.03%	$21.2M	12.9M	-296,111	-2.25%	$1.65	Q4 2024
9/30/2024	2.72%		$46.1M	13.2M			$3.50	Q3 2024
6/30/2024	2.61%		$43.2M	13.2M			$3.28	Q2 2024
3/31/2024	3.55%		$96.7M	13.2M			$7.34	Q1 2024
12/31/2023	1.76%	+0.01%	$49.3M	13.2M	+44,630	+0.34%	$3.74	Q4 2023
9/30/2023	1.32%		$27.8M	13.1M			$2.12	Q3 2023
6/30/2023	2.4%	+0.03%	$62.5M	13.1M	+167,205	+1.29%	$4.76	Q2 2023
3/31/2023	3.2%		$73.9M	13M			$5.70	Q1 2023
12/31/2022	5.35%		$131M	13M			$10.09	Q4 2022
9/30/2022	11.3%		$290M	13M			$22.41	Q3 2022
6/30/2022	12.3%		$321M	13M			$24.78	Q2 2022
3/31/2022	15.7%		$502M	13M			$38.77	Q1 2022
12/31/2021	17.2%		$758M	13M			$58.51	Q4 2021
9/30/2021	13.4%		$768M	13M			$59.27	Q3 2021
6/30/2021	16.6%		$1.12B	13M			$86.79	Q2 2021
3/31/2021	15%	+0.33%	$1.07B	13M	+327,485	+2.59%	$82.45	Q1 2021
12/31/2020	13.9%		$1.15B	12.6M			$90.93	Q4 2020
9/30/2020	9.27%		$505M	12.6M			$39.97	Q3 2020
6/30/2020	8%	+0.89%	$433M	12.6M	+1,412,928	+12.6%	$34.31	Q2 2020
3/31/2020	6.98%		$249M	11.2M			$22.21	Q1 2020
12/31/2019	5.25%		$220M	11.2M			$19.57	Q4 2019
9/30/2019	5.83%	+0.45%	$174M	11.2M	+857,143	+8.27%	$15.53	Q3 2019
6/30/2019	5.95%		$210M	10.4M			$20.30	Q2 2019
3/31/2019	5.33%		$182M	10.4M			$17.57	Q1 2019
12/31/2018	5.35%		$133M	10.4M			$12.83	Q4 2018
9/30/2018	5.19%	+1.86%	$169M	10.4M	+3,703,704	+55.6%	$16.29	Q3 2018
6/30/2018	2.56%		$75.5M	6.66M			$11.34	Q2 2018
3/31/2018	2.53%	+0.45%	$65M	6.66M	+1,190,476	+21.8%	$9.76	Q1 2018
12/31/2017	1.45%	+1.08%	$33.4M	5.47M	+4,046,428	+285%	$6.11	Q4 2017
9/30/2017	0.28%		$5.62M	1.42M			$3.96	Q3 2017
6/30/2017	0.28%		$4.6M	1.42M			$3.24	Q2 2017
3/31/2017	0.42%		$6.46M	1.42M			$4.55	Q1 2017
12/31/2016	0.31%	0%	$3.56M	1.42M	-6,100	-0.43%	$2.51	Q4 2016
9/30/2016	0.35%	-0.02%	$4.45M	1.43M	-77,022	-5.13%	$3.12	Q3 2016
6/30/2016	0.24%	+0%	$2.55M	1.5M	+15,200	+1.02%	$1.70	Q2 2016
3/31/2016	0.27%	-0.16%	$2.68M	1.49M	-884,021	-37.3%	$1.80	Q1 2016
12/31/2015	0.6%	+0.07%	$7.99M	2.37M	+296,165	+14.3%	$3.37	Q4 2015
9/30/2015	0.84%	+0.03%	$11.1M	2.07M	+67,390	+3.36%	$5.33	Q3 2015
6/30/2015	1.06%	+1.06%	$13M	2.01M	+2,007,446	NEW	$6.47	Q2 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.